NASDAQ:ELAB PMGC Q4 2025 Earnings Report $4.51 -0.01 (-0.11%) As of 10:18 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast PMGC EPS ResultsActual EPS-$527.57Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APMGC Revenue ResultsActual Revenue$0.30 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/APMGC Announcement DetailsQuarterQ4 2025Date3/30/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile PMGC Earnings HeadlinesHead-To-Head Analysis: PMGC (NASDAQ:ELAB) vs. L3Harris Technologies (NYSE:LHX)September 21, 2026 | americanbankingnews.comPMGC Holdings Announces Interest-Bearing Payment Agreement Securing NorthStrive Biosciences’ Royalty Cash Flows Through 2031September 18, 2026 | quiverquant.comQTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.September 25 at 1:00 AM | Banyan Hill Publishing (Ad)PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health HoldingsSeptember 18, 2026 | globenewswire.comPMGC Holdings Inc. (ELAB)September 12, 2026 | finance.yahoo.comNorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential ...September 1, 2026 | finance.yahoo.comSee More PMGC Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email. Email Address About PMGCPMGC (NASDAQ:ELAB) was a special purpose acquisition company that completed a business combination with Elevai Labs, Inc. Following the transaction, the combined company operates under the Elevai Labs name and trades on the Nasdaq under the symbol ELAB. Elevai Labs is a biotechnology and medical aesthetics company focused on developing and commercializing physician-dispensed skincare and regenerative aesthetic products. Its research and product development activities center on aesthetic treatments designed to support skin health, rejuvenation and post-procedure care. The company serves the professional aesthetics market through products intended for use by physicians and other qualified medical providers. Elevai Labs is headquartered in California and has focused its commercial activities primarily on the United States. Information about its current leadership and the full scope of its international operations was not available from the information provided.View PMGC ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Super Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketCintas Raises Guidance as a Major Catalyst Moves Closer3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just Strengthened Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
